About us

Van Leeuwenhoeck Research (VLR) is an independent research company, enabling institutional investors and other professional investors to better understand the real value of innovative Life Sciences companies they invest in. VLR can tap into a selected circle of top analysts in Life Sciences, who assist us in conducting fundamental biotech research according to our high standards.

VLR conduct fundamental financial research, independently from any specific broker, bank, or investor. The VLR valuation model Pre-Size® is a three-dimensional model featuring product development through all development phases for all products in the pipeline. This valuation model is much more sophisticated than the common NPV-based valuation methods, which are very difficult to use in making a proper valuation of innovative companies.
Our focus is on biotech/lifesciences companies, both listed on the stock exchange and private, engaged in product development for human use.

VLR selects private and listed life sciences companies for its research. VLR digs deeper than most other research institutes. Our knowledge of the sector combined with our active network of well respected scientists and biotech business analysts add important value to our research.